We are looking to cooperate with experts to be engaged in R&D expert review of VC projects associated with new developments of pharmaceuticals and technologies in the field of medicine.
Cooperation with external experts is subject to a paid basis.
To participate in R&D expert review activities the experts must obtain accreditation (see below).
The work with experts is based on the following:
Accredited experts subject to the expert review shall assess a scientific value of the VC project under review for potential investment pursuant to standard terms of reference. Impersonal consolidated expert report shall be generated following the results of assessment.
For more information concerning R&D expert review process in RusnanoMedInvest, LLC please go here.
Major expert enrollment criteria:
To join our expert team:
The right to verify information provided is vested in RusnanoMedInvest, LLC.
Please note that filled form is not subject to instant accreditation as an expert.
The contract on the expertise is offered by D-Pharma LTD – the management company of RusnanoMedInvest.
NovaMedica, a Russian pharmaceutical company (RUSNANO portfolio company), started operation of the Technology Center designed for the development and pilot production of innovative drug products. It comprises a complex of R&D laboratories and production areas with technological capabilities which are unique for the Russian pharmaceutical industry and one of the best in Europe. Crucial tasks of the Technology Center are to develop the advanced oral medical products of different pharmacotherapeutic groups, including those to treat cardiovascular and gastroenterological diseases, central nervous system diseases, and to create painkillers drugs of the new generation.
26 May 2017
26 May 2017